Science and Services
Proven Expertise in Cellular Therapy
Dendreon is a commercial-stage biopharmaceutical company and end-to-end provider of manufacturing services for the cellular therapy market. We were the first company to successfully develop and commercialize an immunotherapy made from a patient’s own cells, gaining FDA-approval for PROVENGE® (sipuleucel-T) in 2010.
Building on our achievements and expertise needed to commercialize new treatments, we are now working with partners to help drive innovative cell therapies through clinical trials and commercialization with facilities designed to support the entire manufacturing journey.
Cellular Therapy Manufacturing
We are helping companies to bring life-saving innovations to market. From clinical research to manufacturing, Dendreon has the experience, knowledge and logistics to assist in the development and production of the next game-changing cell therapy.
Our flagship product, PROVENGE® (sipuleucel-T), was the first FDA-approved immunotherapy to harness the intrinsic benefits of personalized cellular treatment constructed from a patient’s own immune cells.
Dendreon aims to stay at the forefront of development, manufacturing, and commercialization of immunotherapies that harness the power of the body’s immune system to help extend patients’ lives. We contribute research to advance the understanding of cellular therapies and further enable the delivery of specialized treatments.